{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T07:24:21Z","timestamp":1761290661054,"version":"build-2065373602"},"reference-count":6,"publisher":"Bentham Science Publishers Ltd.","issue":"1","license":[{"start":{"date-parts":[[2009,9,25]],"date-time":"2009-09-25T00:00:00Z","timestamp":1253836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/legalcode"}],"content-domain":{"domain":["openophthalmologyjournal.com","benthamopen.com"],"crossmark-restriction":true},"short-container-title":["TOOPHTJ"],"published-print":{"date-parts":[[2009,9,25]]},"abstract":"<jats:p>We present a 78-year-old patient who developed refractory glaucoma following a fungal infection of the corneal incision after cataract extraction with posterior chamber intraocular lens implantation. An anterior chamber injection of 0.1 ml recombinant tissue plasminogen activator (25 mcg\/0.1 mL) was performed to improve the trabecular meshwork outflow facility compromised secondary to fibrin blockade. The intraocular pressure dropped dramatically from 48 mmHg to 10 mmHg postoperatively, negating the need for glaucoma surgery.<\/jats:p>","DOI":"10.2174\/1874364100903010075","type":"journal-article","created":{"date-parts":[[2009,9,28]],"date-time":"2009-09-28T11:27:03Z","timestamp":1254137223000},"page":"75-76","update-policy":"https:\/\/doi.org\/10.2174\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Intracameral Recombinant Tissue Plasminogen Activator for Refractory Glaucoma Secondary to a Fungal Corneal Abscess"],"prefix":"10.2174","volume":"3","author":[{"given":"L. Jay","family":"Katz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oana","family":"Stirbu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Garth","family":"Willis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parul","family":"Ichhpujani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"refR1","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/BF00186522","volume":"234","author":"Laatikainen L","year":"1996","unstructured":"Laatikainen L, Mattila J. \n                        The use of tissue plasminogen activator in posttraumatic hyphema \n                        Graefes Arch Clin Exp Ophthalmol  \n                        1996; \n                        234\n                        : 67-8.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"refR2","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0886-3350(97)80246-5","volume":"23","author":"Wedrich A","year":"1997","unstructured":"Wedrich A, Menapace R, Ries E, et al. \n                        Intracameral tissue plasminogen activator to treat severe fibrinous effusion after cataract surgery \n                        J Cataract Refract Surg  \n                        1997; \n                        23\n                        : 873-7.","journal-title":"J Cataract Refract Surg"},{"key":"refR3","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0886-3350(99)80083-2","volume":"25","author":"Klais CM","year":"1999","unstructured":"Klais CM, Hattenbach LO, Steinkamp GWK, et al. \n                        Intraocular recombinant tissue plasminogen activator fibrinolysis of fibrin formation after cataract surgery in children \n                        J Cataract Refract Surg  \n                        1999; \n                        25\n                        : 357- 61.","journal-title":"J Cataract Refract Surg"},{"key":"refR4","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1001\/archopht.120.11.1487","volume":"120","author":"Zalta AH","year":"2002","unstructured":"Zalta AH, Sweeney CP, Zalta AK, Kaufman AH. \n                        Intracameral tissue plasminogen activator use in a large series of eyes with valved glaucoma drainage implants \n                        Arch Ophthalmol  \n                        2002; \n                        120\n                        : 1487-93.","journal-title":"Arch Ophthalmol"},{"key":"refR5","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0161-6420(96)30704-5","volume":"103","author":"Lundy DC","year":"ions","unstructured":"Lundy DC, Sidoti P, Winarko T, et al. \n                        Intracameral tissue plasminogen activator after glaucoma surgery. Indications, effectiveness, and complications. \n                        Ophthalmology  \n                        ions; \n                        103\n                        : 274-82.","journal-title":"Ophthalmology"},{"key":"refR6","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/S0161-6420(01)00648-0","volume":"108","author":"Hattenbach LO","year":"2001","unstructured":"Hattenbach LO, Klais C, Koch FH, et al. \n                        Intravitreous injection of tissue plasminogen activator and gas in the treatment of submacular hemorrhage under various conditions \n                        Ophthalmology  \n                        2001; \n                        108\n                        : 1485-92.","journal-title":"Ophthalmology"}],"container-title":["The Open Ophthalmology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/openophthalmologyjournal.com\/contents\/volumes\/V3\/TOOPHTJ-3-75\/TOOPHTJ-3-75.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/openophthalmologyjournal.com\/contents\/volumes\/V3\/TOOPHTJ-3-75\/TOOPHTJ-3-75.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/openophthalmologyjournal.com\/contents\/volumes\/V3\/TOOPHTJ-3-75\/TOOPHTJ-3-75.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T07:21:14Z","timestamp":1761290474000},"score":1,"resource":{"primary":{"URL":"https:\/\/openophthalmologyjournal.com\/VOLUME\/3\/PAGE\/75\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9,25]]},"references-count":6,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,9,25]]}},"alternative-id":["TOOPHTJ-3-75"],"URL":"https:\/\/doi.org\/10.2174\/1874364100903010075","relation":{},"ISSN":["1874-3641"],"issn-type":[{"type":"print","value":"1874-3641"}],"subject":[],"published":{"date-parts":[[2009,9,25]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2009-06-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2009-07-23","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2009-08-31","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2009-09-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}